Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Chada

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Genetics|January 24, 2002
Molecular characterization of the mouse In(10)17Rk inversion and identification of a novel muscle-specific gene at the proximal breakpointKathleen F Benson, Kiran Chada
International Journal of Molecular Sciences|May 6, 2020
High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial NeoplasiaUchenna Unachukwu, Kiran Chada, Jeanine D'Armiento
Cancer Genetics and Cytogenetics|June 5, 2003
HMGA2 is expressed in an allele-specific manner in human lipomasHena R Ashar, Alexei Tkachenko, Pritesh Shah, et al.
Developmental Biology|June 30, 2026
Secreted Frizzled-Related Protein 1 Controls Distal Lung Formation via Wnt and PDGF SignalingNooralam A Rai, Tina Zelonina, Kiran Chada, et al.
Cell|October 30, 2008
Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf ExpressionJinsuke Nishino, Injune Kim, Kiran Chada, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 22, 2002
Hmgi-c-independent Activation of MuRantes in VivoJohn F Schiltz, Krishna Kesari, Hena R Ashar, et al.
Biochimica Et Biophysica Acta|February 4, 2010
In vivo modulation of HMGA2 expressionHena R Ashar, Roland A Chouinard, Madhavi Dokur, et al.
Iscience|July 5, 2021
Renal neoplasms in tuberous sclerosis mice are neurocristopathiesUchenna Unachukwu, Takayuki Shiomi, Monica Goldklang, et al.
Cancer Research|February 4, 2016
Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway ActivationJeanine D'Armiento, Takayuki Shiomi, Sarah Marks, et al.
Molecular Cancer Therapeutics|May 1, 2023
Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of ApoptosisUchenna Unachukwu, Jarrod Sonett, Denzel Woode, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Genetics|January 24, 2002
Molecular characterization of the mouse In(10)17Rk inversion and identification of a novel muscle-specific gene at the proximal breakpointKathleen F Benson, Kiran Chada
International Journal of Molecular Sciences|May 6, 2020
High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial NeoplasiaUchenna Unachukwu, Kiran Chada, Jeanine D'Armiento
Cancer Genetics and Cytogenetics|June 5, 2003
HMGA2 is expressed in an allele-specific manner in human lipomasHena R Ashar, Alexei Tkachenko, Pritesh Shah, et al.
Developmental Biology|June 30, 2026
Secreted Frizzled-Related Protein 1 Controls Distal Lung Formation via Wnt and PDGF SignalingNooralam A Rai, Tina Zelonina, Kiran Chada, et al.
Cell|October 30, 2008
Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf ExpressionJinsuke Nishino, Injune Kim, Kiran Chada, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|January 22, 2002
Hmgi-c-independent Activation of MuRantes in VivoJohn F Schiltz, Krishna Kesari, Hena R Ashar, et al.
Biochimica Et Biophysica Acta|February 4, 2010
In vivo modulation of HMGA2 expressionHena R Ashar, Roland A Chouinard, Madhavi Dokur, et al.
Iscience|July 5, 2021
Renal neoplasms in tuberous sclerosis mice are neurocristopathiesUchenna Unachukwu, Takayuki Shiomi, Monica Goldklang, et al.
Cancer Research|February 4, 2016
Mesenchymal Tumorigenesis Driven by TSC2 Haploinsufficiency Requires HMGA2 and Is Independent of mTOR Pathway ActivationJeanine D'Armiento, Takayuki Shiomi, Sarah Marks, et al.
Molecular Cancer Therapeutics|May 1, 2023
Tyrosine Kinase Inhibitors Diminish Renal Neoplasms in a Tuberous Sclerosis Model Via Induction of ApoptosisUchenna Unachukwu, Jarrod Sonett, Denzel Woode, et al.
Pageof 3